ViroCell
ViroCell Biologics manufactures viral vectors and gene-modified cells to enable novel cell and gene therapies (CGTs) to enter clinical trials.
ViroCell Biologics manufactures viral vectors and gene-modified cells to enable novel cell and gene therapies (CGTs) to enter clinical trials.
ViroCell Biologics manufactures viral vectors and gene-modified cells to enable novel cell and gene therapies (CGTs) to enter clinical trials.
Leveraging the team’s 20-year track record of manufacturing more than 100 unique vectors, ViroCell is helping to accelerate the development of crucial, cutting edge therapies so that disease can recede and progress can prevail.
ViroCell is working in partnership with the Royal Free Hospital and Great Ormond Street Hospital.
Website: www.virocell.com
02/09/2024
A £175 million communications network connecting 163 remote radio sites across 11,000 miles of UK coastline is now operational ensuring His Majesty’s (HM) Coastguard’s effective frontline emergency response continues for thousands of distress calls from the UK’s waters.
12/06/2024
LS EcoEnergy (CEO Lee Sang-ho) announced on the 12th that the company has entered into negotiations to secure the land for a submarine cable project in the UK.
LS EcoEnergy is actively engaged in negotiations toleaseland atthe Port of Tyne in the northeast. The size of the project site, including the port, is approximately154,711㎡.LS EcoEnergy plans to conclude negotiations ‒ including land lease conditions ‒ within the year.
Click the link in the title to read full article.
12/06/2024
More than 30,000 students and staff at the University of Bristol will soon have access to a new and improved Wi-Fi experience thanks to a major new wireless network project that will be delivered by Telent. It will be one of the largest education networks outside of North America, with the capacity to support over 300,000 devices.
Click the link in the title to read more
04/06/2024
As part of Telent’s Environment and Sustainability vision, Telent’s dedicated Green Solutions team have been exploring and developing a range of innovative Green Solutions to benefit the environment, customers and it’s supply chain to improve sustainability and reduce its carbon footprint.
Click the link in the title to read more
29/05/2024
PIC, a specialist insurer of defined benefit pension schemes, has concluded a £204 million full buy-in of the Arqiva Defined Benefit Pension Plan (“the Plan”). The transaction secures the pensions of both deferred and pensioner members of the Plan, which is sponsored by Arqiva Limited (“the Company”), a British telecommunications company, comprising 589 current pensioners and dependents and 215 deferred members.
Click the link in the title to read more
27/05/2024
Multiple updates announced from Global Interconnection Group Limited, including:
Global InterConnection Group negotiations to build HVDC cable factory at Port of Tyne
In Joint Venture with one of the subsidiaries of LS Group, Korea
Global InterConnection Group to appoint new CEO
Click the link in the title to read more